Bayer has received FDA approval to sell its Mirena intrauterine device as a treatment for heavy menstrual bleeding. The company said its product is the first contraceptive system approved by the agency for such indication.
Published in Brief:
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||